{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T13:24:57Z","timestamp":1785763497241,"version":"3.56.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Type 2 Diabetes Mellitus (T2DM), dyslipidemia, and periodontitis are interconnected conditions that exacerbate systemic inflammation and metabolic dysregulation. Understanding the molecular and clinical profiles of these comorbidities is crucial for developing targeted interventions. This study investigates the molecular and clinical profiles of individuals with T2DM, dyslipidemia, and periodontitis to identify key markers and pathways underlying disease severity and progression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Peripheral blood mononuclear cells (PBMCs) were analyzed from five patient groups: T2DM poorly controlled with dyslipidemia and periodontitis (T2DMpoorly-DLP-H), T2DM well-controlled with dyslipidemia and periodontitis (T2DMwell-DLP-H), dyslipidemia and periodontitis (DL-P), periodontitis alone (P), and healthy controls (H). Correlations between molecular and clinical markers were assessed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The T2DMpoorly-DLP-H group exhibited the most extensive molecular dysregulation, including unique upregulation of <jats:italic>Plasminogen Activator<\/jats:italic>, Tissue <jats:italic>Type (PLAT)<\/jats:italic> and consistent overexpression of <jats:italic>Vanin-1 (VNN1)<\/jats:italic>, a key regulator of oxidative stress. HbA1c and fasting plasma glucose were highest in this group (HbA1c &amp;gt;12%, glucose &amp;gt;300 mg\/dL), correlating strongly (R\u00b2 = 0.88, <jats:italic>p<\/jats:italic> &amp;lt; 0.001). In contrast, the T2DMwell-DLP-H group demonstrated reduced gene dysregulation and improved glycemic control (HbA1c ~6.5%). Sex-specific differences were observed, with females exhibiting higher glycemic markers (<jats:italic>p<\/jats:italic> = 0.014) and males showing elevated lipid levels (<jats:italic>p<\/jats:italic> = 0.021).<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>This study identifies <jats:italic>Vanin-1 (VNN1)<\/jats:italic> as a potential biomarker for systemic inflammation and highlights the role of <jats:italic>Plasminogen Activator, Tissue Type (PLAT)<\/jats:italic> in vascular dysfunction, emphasizing the critical importance of glycemic control in mitigating molecular and clinical dysregulation. These findings underscore the need for personalized, sex-specific strategies to manage these comorbidities effectively.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1574392","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T04:10:50Z","timestamp":1747627850000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Molecular and clinical profiles of T2DM, dyslipidemia, and periodontitis: insights into inflammatory and metabolic dysregulation"],"prefix":"10.3389","volume":"16","author":[{"given":"Peace Ngozi","family":"Okoro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Oche","family":"Ambrose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor Emmanuel","family":"Obaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chidiebere Valentine","family":"Ugwueze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. K.","family":"Olarinoye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olalekan A.","family":"Agede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-S062","article-title":"Diagnosis and classification of diabetes mellitus","volume":"33","year":"2010","journal-title":"Diabetes Care"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.6.1615","article-title":"The pathobiology of diabetic complications: a unifying mechanism","volume":"54","author":"Brownlee","year":"2005","journal-title":"diabetes"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-0045","article-title":"Insulin resistance and hyperinsulinemia: you can\u2019t have one without the other","volume":"31","author":"Kim","year":"2008","journal-title":"Diabetes Care"},{"key":"B4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00125-011-2342-y","article-title":"Periodontitis and diabetes: a two-way relationship","volume":"55","author":"Preshaw","year":"2012","journal-title":"Diabetologia"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000091257.27563.32","article-title":"Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I","volume":"108","author":"Creager","year":"2003","journal-title":"Circulation"},{"key":"B6","doi-asserted-by":"crossref","DOI":"10.1007\/s00125-015-3525-8","article-title":"Pathophysiology of diabetic dyslipidaemia: where are we","volume":"58","author":"Verg\u00e8s","year":"2015","journal-title":"Diabetologia"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.sdentj.2020.09.003","article-title":"Age of the donor affects the nature of in vitro cultured human dental pulp stem cells","volume":"33","author":"Alzer","year":"2021","journal-title":"Saudi Dental J"},{"key":"B8","doi-asserted-by":"publisher","first-page":"8267234","DOI":"10.1155\/2019\/8267234","article-title":"Biomarkers of oxidative stress in metabolic syndrome and associated diseases","volume":"2019","author":"Vona","year":"2019","journal-title":"Oxid Med Cell Longevity"},{"key":"B9","unstructured":"Kaskow\n              B\n            \n          \n          Crawley, Australia\n          University of Western Australia\n          Molecular characterisation of genetic variants in Vanin 1 (VNN1): a novel cardiovascular disease gene\n          \n          2013"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1042\/BST20140092","article-title":"Role of the Vnn1 pantetheinase in tissue tolerance to stress","volume":"42","author":"Naquet","year":"2014","journal-title":"Biochem Soc Trans"},{"key":"B11","doi-asserted-by":"publisher","first-page":"6022","DOI":"10.3390\/ijms23116022","article-title":"An insight into recent advances on platelet function in health and disease","volume":"23","author":"Chaudhary","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2017.08.009","article-title":"Overweight, hyperglycemia and tobacco use are modifiable risk factors for onset of retinopathy 9 and 17 years after the diagnosis of diabetes\u2013a retrospective observational nation-wide cohort study","volume":"133","author":"Tyrberg","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"B13","doi-asserted-by":"crossref","DOI":"10.1007\/0-387-21679-0_4","article-title":"An R package for analyses of Affymetrix oligonucleotide arrays","author":"Irizarry","year":"2003","journal-title":"Anal Gene Expression data: Methods softw"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btq431","article-title":"A framework for oligonucleotide microarray preprocessing","volume":"26","author":"Carvalho","year":"2010","journal-title":"Bioinformatics"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B16","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/wics.147","article-title":"ggplot2","volume":"3","author":"Wickham","year":"2011","journal-title":"Wiley interdisciplinary reviews: computational statistics"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-12-35","article-title":"VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in R","volume":"12","author":"Chen","year":"2011","journal-title":"BMC Bioinf"},{"key":"B18","article-title":"Package \u2018corrplot\u2019","volume":"56","author":"Wei","year":"2017","journal-title":"Statistician"},{"key":"B19","article-title":"Package \u2018AnnotationDbi\u2019","author":"Pages","year":"2017","journal-title":"Bioconduct Packag Maint"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"J Open Source softw"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2011.11.006","article-title":"Inflammation and type 2 diabetes","volume":"38","author":"Calle","year":"2012","journal-title":"Diabetes Metab"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.3390\/ijms20163891","article-title":"Vanin 1: its physiological function and role in diseases","volume":"20","author":"Bartucci","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biochi.2022.08.004","article-title":"Structural and functional properties of rBmTI-A: A Kunitz-BPTI serine protease inhibitor with therapeutical potential","volume":"204","author":"Ferreira","year":"2023","journal-title":"Biochimie"},{"key":"B24","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1210\/endrev\/bnaa008","article-title":"Adrenal incidentaloma","volume":"41","author":"Sherlock","year":"2020","journal-title":"Endocr Rev"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2018.12.002","article-title":"Patients with type 1 diabetes in a tertiary setting do not attain recommended lipid targets","volume":"46","author":"Lan","year":"2020","journal-title":"Diabetes Metab"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S386506","article-title":"Vanin 1 gene role in modulation of iNOS\/MCP-1\/TGF-\u03b21 signaling pathway in obese diabetic patients","author":"Mosaad","year":"2022","journal-title":"J Inflammation Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht149","article-title":"Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I","volume":"34","author":"Paneni","year":"2013","journal-title":"Eur Heart J"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2010.02265.x","article-title":"New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR)","volume":"268","author":"Eeg-Olofsson","year":"2010","journal-title":"J Internal Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2015.156","article-title":"Cancer target of mitotane identified","volume":"11","author":"Holmes","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"New Engl J Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","year":"2008","journal-title":"New Engl J Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2016.158","article-title":"Catheter ablation in pole position for AF treatment","volume":"13","author":"Ummarino","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"B33","unstructured":"Alshammari\n              MA\n            \n          \n          Dayton, Ohio\n          Wright State University\n          Impaired \u03b2-cell neogenesis in a mouse model of metabolic syndrome\n          \n          2022"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13293-015-0033-y","article-title":"Sex differences in metabolic homeostasis, diabetes, and obesity","volume":"6","author":"Mauvais-Jarvis","year":"2015","journal-title":"Biol sex Dif"},{"key":"B35","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s12265-018-9846-5","article-title":"Sex and gender differences in ischemic heart disease: endocrine vascular disease approach (EVA) study design","volume":"13","author":"Raparelli","year":"2020","journal-title":"J Cardiovasc Trans Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.114.100305","article-title":"Dietary cholesterol and cardiovascular disease: a systematic review and meta-analysis","volume":"102","author":"Berger","year":"2015","journal-title":"Am J Clin Nutr"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-09-304931","article-title":"The role of vanin-1 and oxidative stress\u2013related pathways in distinguishing acute and chronic pediatric ITP","volume":"117","author":"Zhang","year":"2011","journal-title":"Blood J Am Soc Hematol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.115.306249","article-title":"Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology","volume":"118","author":"Nordestgaard","year":"2016","journal-title":"Circ Res"},{"key":"B39","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/eurheartj\/ehv598","article-title":"Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes","volume":"37","author":"Regitz-Zagrosek","year":"2016","journal-title":"Eur Heart J"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2018.00001","article-title":"Thrombosis and vascular inflammation in diabetes: mechanisms and potential therapeutic targets","volume":"5","author":"Pechlivani","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1210\/er.2015-1137","article-title":"Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus","volume":"37","author":"Kautzky-Willer","year":"2016","journal-title":"Endocr Rev"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1574392\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T04:10:54Z","timestamp":1747627854000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1574392\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":41,"alternative-id":["10.3389\/fendo.2025.1574392"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1574392","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,19]]},"article-number":"1574392"}}